Free Trial

Societe Generale's Rating of AbbVie on 11/23/2021

On November 23, 2021, Societe Generale updated its outlook on AbbVie (NYSE:ABBV) with the action "Upgrade", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.